90 related articles for article (PubMed ID: 9795194)
41. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
42. 3-Hydroxy-3-methylglutaryl coenzyme a reductase activity in liver of athymic mice with or without an implanted human carcinoma.
Polo M; de Bravo MG; Carbone C
Comp Biochem Physiol B Biochem Mol Biol; 1999 Apr; 122(4):433-7. PubMed ID: 10392455
[TBL] [Abstract][Full Text] [Related]
43. HMGCoA reductase and cholesterol 7 alpha-hydroxylase in human liver.
Bosisio E; Cighetti G; Galli Kienle M; Tritapepe R; Galli G
Life Sci; 1984 May; 34(21):2075-81. PubMed ID: 6727552
[TBL] [Abstract][Full Text] [Related]
44. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
45. 3-Hydroxy-3-methylglutaryl coenzyme A reductase localization in rat liver peroxisomes and microsomes of control and cholestyramine-treated animals: quantitative biochemical and immunoelectron microscopical analyses.
Keller GA; Pazirandeh M; Krisans S
J Cell Biol; 1986 Sep; 103(3):875-86. PubMed ID: 3745272
[TBL] [Abstract][Full Text] [Related]
46. Effects of cortisol or corticotropin administration on hepatic 3-hydroxy-3-methylglutaryl-CoA reductase activity and plasma lipids in the pregnant rat and fetuses.
Innis SM; Haave NC
J Dev Physiol; 1989 Jun; 11(6):346-50. PubMed ID: 2556470
[TBL] [Abstract][Full Text] [Related]
47. Hepatic cholesterol metabolism in obesity: activity of microsomal 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Angelin B; Backman L; Einarsson K; Eriksson L; Ewerth S
J Lipid Res; 1982 Jul; 23(5):770-3. PubMed ID: 7119574
[TBL] [Abstract][Full Text] [Related]
48. Hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in hamsters on a lithogenic diet.
Ginsberg RL; Duane WC; Flock EV
J Lab Clin Med; 1977 May; 89(5):928-36. PubMed ID: 858970
[TBL] [Abstract][Full Text] [Related]
49. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
Ness GC; Holland RC; Lopez D
Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
[TBL] [Abstract][Full Text] [Related]
50. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
Powell EE; Kroon PA
J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149
[TBL] [Abstract][Full Text] [Related]
51. 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse.
Lee SJ; Ko JH; Lim K; Lim KT
Pharmacol Res; 2005 May; 51(5):399-408. PubMed ID: 15749454
[TBL] [Abstract][Full Text] [Related]
52. Regulation of cholesterol biosynthesis in HeLa S3G cells by serum lipoproteins: dexamethasone-mediated interference with suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Cavenee WK; Johnston D; Melnykovych G
Proc Natl Acad Sci U S A; 1978 May; 75(5):2103-7. PubMed ID: 209449
[TBL] [Abstract][Full Text] [Related]
53. Hepatic cholesterol metabolism in normo- and hyperlipidemic patients with cholesterol gallstones.
Ahlberg J; Angelin B; Björkhem I; Einarsson K; Leijd B
J Lipid Res; 1979 Jan; 20(1):107-15. PubMed ID: 374662
[TBL] [Abstract][Full Text] [Related]
54. Dietary regulation of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase and cholesterol synthetic activities in fasted-refed rats.
Ide T; Gotoh Y; Sugano M
J Nutr; 1980 Jan; 110(1):158-68. PubMed ID: 7354379
[TBL] [Abstract][Full Text] [Related]
55. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols.
Ness GC
Biochim Biophys Acta; 2015 May; 1851(5):667-73. PubMed ID: 25701719
[TBL] [Abstract][Full Text] [Related]
56. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes.
Singer II; Scott S; Kazazis DM; Huff JW
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5264-8. PubMed ID: 3293052
[TBL] [Abstract][Full Text] [Related]
57. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
58. Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothyronine administration: possible linkage of cholesterol synthesis to biliary secretion.
Day R; Gebhard RL; Schwartz HL; Strait KA; Duane WC; Stone BG; Oppenheimer JH
Endocrinology; 1989 Jul; 125(1):459-68. PubMed ID: 2737158
[TBL] [Abstract][Full Text] [Related]
59. Differential activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in zones of the adrenal cortex.
Kubo M; Strott CA
Endocrinology; 1987 Jan; 120(1):214-21. PubMed ID: 3023027
[TBL] [Abstract][Full Text] [Related]
60. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
